| Structure | Chemical Name | CAS | MF |
|
D-Leucine, N-(4,6-dichloro-1,3,5-triazin-2-yl)-N-4-pentyn-1-yl-, methyl ester
|
2362527-67-9
|
C15H20Cl2N4O2
|
|
4(1H)-Pyridinone, 2-[[(6-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethyl-
|
2362529-32-4
|
C16H17N3O3S
|
|
CWHM-1008
|
2362539-97-5
|
C22H26F3N3O
|
|
[1,1'-Biphenyl]-4-carboxaldehyde, 4'-(diphenylamino)-3-hydroxy-
|
2363049-63-0
|
C25H19NO2
|
|
Bicyclo[1.1.1]pentane, 1-(difluoromethyl)-3-iodo-
|
2363075-15-2
|
C6H7F2I
|
|
Ezetimibe Impurity 94
|
2363086-22-8
|
C33H30F2N2O5
|
|
DBCO-PEG5-DBCO
|
2363130-04-3
|
C50H54N4O9
|
|
Palbociclib Impurity 33
|
2363160-84-1
|
C22H24N6O4
|
|
Anti-Vacuolar ATP synthase membrane sector-associated protein M8-9 antibody produced in rabbit
|
2363165-42-6
|
C37H47N5O4S
|
|
c-Kit-IN-3
|
2363169-01-9
|
C26H20ClF3N2O4
|
|
Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-2-[(5-amino-2-pyridinyl)amino]-8-cyclopentyl-5-methyl-
|
2363172-64-7
|
C20H22N6O2
|
|
4',5'-bis(4-formylphenyl)-3',6'-dimethyl-[1,1':2',1''-terphenyl]-4,4''-dicarbaldehyde
|
2363716-37-2
|
C36H26O4
|
|
3',6'-difluoro-4',5'-bis(4-formylphenyl)-[1,1':2',1''-terphenyl]-4,4''-dicarbaldehyde
|
2363716-48-5
|
C34H20F2O4
|
|
Rhodamine-N3 chloride
|
2363751-90-8
|
C44H59ClN8O7
|
|
Biotin-PEG8-azide
|
2363756-34-5
|
C28H52N6O10S
|
|
Azido-PEG12-NHS ester
|
2363756-50-5
|
C31H56N4O16
|
|
Benzene-1,2,3,5-d4, 4-bromo-6-iodo-
|
2363787-31-7
|
C6BrD4I
|
|
2-[5-(Benzyloxy)pentyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
2364334-02-9
|
C18H29BO3
|
|
PROTAC B-Raf degrader 1
|
2364367-27-9
|
C36H37N5O12S
|
|
C8IC
|
2364382-27-2
|
C94H76Cl4N4O2S6
|
|
T8IC
|
2364382-30-7
|
C90H76N4O2S8
|
|
Propanedinitrile, 2-(5-chloro-2,3-dihydro-3-oxo-1H-inden-1-ylidene)-
|
2364382-35-2
|
C12H5ClN2O
|
|
Methyl 5,6-dimethoxynicotinate
|
2364452-54-8
|
C9H11NO4
|
|
5'-(4-carbamimidoylphenyl)-[1,1':3',1''-terphenyl]-4,4''-bis(carboximidamide),hydrochloride(1:3)
|
2364456-55-1
|
C27H25ClN6
|
|
Benzenepropanamide, α-[[1,4-dihydro-4-(hydroxyimino)-1-oxo-2-naphthalenyl]amino]-N-(3,5-dimethoxyphenyl)-, (αR)-
|
2364458-49-9
|
C27H25N3O5
|
|
"4-((4-(11-(acryloyloxy)undecyloxy)phenoxy) carbonyl)phenyl 4-(11-(acryloyloxy) undecyloxy)benzoate"
|
2364488-44-6
|
C48H62O10
|
|
FMF-04-159-2
|
2364489-81-4
|
C28H30Cl3N7O5S
|
|
1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl-
|
2364554-48-1
|
C18H19N5O2
|
|
5-Fluoro-1-methoxymethoxy-3-(trifluoromethyl)benzene
|
2364585-39-5
|
C9H8F4O2
|
|
DBCO-PEG1-NH-Boc
|
2364591-77-3
|
C28H33N3O5
|
|
5-endo-BCN-pentanoic acid
|
2364591-80-8
|
C16H23NO4
|
|
Cefazolin Impurity 12
|
2364623-02-7
|
C14H14N8O5S3(-2)
|
|
DT2216
|
2365172-42-3
|
C77H96ClF3N10O10S4
|
|
Benzamide, 4-[4-[[2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(methylamino)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]-
|
2365172-82-1
|
C44H51ClF3N5O5S3
|
|
Cyclohexanecarboxylic acid, 4-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene]-, ethyl ester
|
2365173-46-0
|
C16H27BO4
|
|
1-Pyrrolidinecarboxylic acid, 3-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene]-, 1,1-dimethylethyl ester, (3E)-
|
2365173-49-3
|
C16H28BNO4
|
|
8-Azabicyclo[3.2.1]octane-8-carboxylic acid, 3-[(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methylene]-, 1,1-dimethylethyl ester
|
2365173-53-9
|
C19H32BNO4
|
|
BrettPhos Pd G6 TES
|
2365275-34-7
|
C47H72BrO4PPdSi
|
|
Cl-PEG6-CH2COOH
|
2365309-92-6
|
C14H27ClO8
|
|
Benzoic acid, 4-[2-(4-bromophenyl)ethynyl]-, methyl ester
|
2365379-82-2
|
C16H11BrO2
|
|
(R)-Azepan-4-ol hydrochloride
|
2365390-45-8
|
C6H14ClNO
|
|
2H-Benzotriazole, 5,6-difluoro-2-(2-hexyldecyl)-4,7-bis[5-(trimethylstannyl)-2-thienyl]-
|
2365391-00-8
|
C36H55F2N3S2Sn2
|
|
Complement C5-IN-1
|
2365402-67-9
|
C24H32N2O6
|
|
Macitentan Impurity 18
|
2365406-85-3
|
C13H15BrN4O3S
|
|
m-PEG3-S-PEG1-t-butyl ester
|
2365419-97-0
|
C16H32O6S
|
|
DipyridaMole EP IMpurity E
|
2365420-11-5
|
C24H40N8O4
|
|
PB-22 4-hydroxyquinoline isomer
|
2365470-96-6
|
C23H22N2O2
|
|
5-fluoro PB-22 5-hydroxyisoquinoline isomer
|
2365471-16-3
|
C23H21FN2O2
|
|
JWH 019 N-(2-fluorohexyl) isomer
|
2365471-41-4
|
C25H24FNO
|
|
AM2201 8-quinolinyl carboxamide
|
2365471-42-5
|
C23H22FN3O
|
|
5-fluoro PB-22 6-hydroxyisoquinoline isomer
|
2365471-44-7
|
C23H21FN2O2
|
|
BB-22 3-hydroxyquinoline isomer
|
2365471-57-2
|
C25H24N2O2
|
|
AB-FUBINACA isomer 2
|
2365471-64-1
|
C20H21FN4O2
|
|
(±)5-epi CP 55,940
|
2365471-91-4
|
C24H40O3
|
|
Nicorandil Impurity 30
|
2365472-37-1
|
C16H18N6O8
|
|
Carbonic acid, [[1′-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-1′,2′,4′,6′-tetrahydro-4′,6′-dioxospiro[cyclopropane-1,3′-[3H]pyrido[1,2-b]pyridazin]-5′-yl]oxy]methyl methyl ester
|
2365473-17-0
|
C27H22F2N2O6S
|
|
Dibenzo[b,e]thiepin-11(6H)-one, 7-fluoro-
|
2365473-57-8
|
C14H9FOS
|
|
trimer
|
2365474-05-9
|
C24H27N7O6+2
|
|
nicorandil trimer 07
|
2365474-06-0
|
C24H27N8O9+
|
|
(2S,4R)-N-(2-(2-(2-(2-((6-Chlorohexyl)oxy)ethoxy)ethoxy)ethoxy)-4-(4-methylthiazol-5-yl)benzyl)-1-((S)-2-(1-cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxamide
|
2365478-58-4
|
C39H56ClN5O8S
|
|
4-Morpholinecarboxylic acid, 2-(hydroxymethyl)-6-methyl-, 1,1-dimethylethyl ester, (2R,6S)-rel-
|
2366178-83-6
|
C11H21NO4
|
|
Naphthalene, 2-(4-chlorophenyl)-1-phenyl-
|
2366210-03-7
|
C22H15Cl
|
|
Benzoic acid, 4-amino-3,5-bis(1-methylethyl)-
|
2366239-13-4
|
C13H19NO2
|
|
MS31
|
2366264-12-0
|
C20H27N3O2
|
|
1,2,3,4,5,6,7,8,9-NONACHLORODECANE
|
2366268-80-4
|
C44H49N13O7
|
|
L-Glutamic acid, N-[4-[[(4S)-4-[[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]amino]-4-carboxy-1-oxobutyl]amino]benzoyl]-
|
2366274-27-1
|
C31H31N9O10
|
|
Benzenemethanamine, 4-(1,1-dimethylethyl)-, hydriodide
|
2366873-27-8
|
C11H18IN
|
|
1H-Pyrrole-1-carboxamide, N-[2-[3-(aminosulfonyl)phenyl]ethyl]-3-ethyl-2,5-dihydro-4-methyl-2-oxo-
|
2366968-77-4
|
C16H21N3O4S
|
|
5-Fluoro-3,3-bis(4-fluorophenyl)benzo[c][1,2]oxaborol-1(3H)-ol
|
2366993-30-6
|
C19H12BF3O2
|
|
Benzeneacetic acid, 5-chloro-2-[(4-methoxyphenyl)methoxy]-
|
2367002-58-0
|
C16H15ClO4
|
|
1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]-
|
2367004-54-2
|
C29H25FN4O5
|
|
D-erythro-Pentofuranoside, [4-(octyloxy)phenyl]methyl 2-deoxy-1,4-dithio-
|
2367016-05-3
|
C20H32O3S2
|
|
L-Lysine, N2-[[[(1S)-4-(1,1-dimethylethoxy)-1-[(1,1-dimethylethoxy)carbonyl]-4-oxobutyl]amino]carbonyl]-N6-[3-(2-naphthalenyl)-L-alanyl]-, 1,1-dimethylethyl ester
|
2367588-01-8
|
C37H56N4O8
|
|
2,4-Pentanedione, 1,5-dicyclopentyl-
|
2367607-54-1
|
C15H24O2
|
|
Brexpiprazole Impurity 53
|
2368233-78-5
|
C25H27N3O3S
|
|
Vortioxetine Impurity 17
|
2368241-98-7
|
C22H22S2
|
|
[4-Methyl-5-(4-piperidinyl)-4H-1,2,4-triazol-3-yl]methanol dihydrochloride hydrate
|
2368828-54-8
|
C9H20Cl2N4O2
|
|
2,2'-Bioxazole, 4,4'-dicyclohexyl-4,4',5,5'-tetrahydro-, (4S,4'S)-
|
2368835-34-9
|
C18H28N2O2
|
|
2,6-di(1H-pyrazol-4-yl)naphthalene
|
2368840-52-0
|
C16H12N4
|
|
1H-Isoindol-1-one, 6-[(1S)-1-[(3S)-3-fluoro-1-pyrrolidinyl]ethyl]-2,3-dihydro-2-[3-[3-[(4-methyl-4H-1,2,4-triazol-3-yl)methyl]-3-oxetanyl]phenyl]-4-(trifluoromethyl)-
|
2368840-65-5
|
C28H29F4N5O2
|
|
1H-?Isoindol-?1-?one, 6-?[(1R)?-?1-?[(3S)?-?3-?fluoro-?1-?pyrrolidinyl]?ethyl]?-?2,?3-?dihydro-?2-?[3-?[3-?[(4-?methyl-?4H-?1,?2,?4-?triazol-?3-?yl)?methyl]?-?3-?oxetanyl]?phenyl]?-?4-?(trifluoromethyl)?-
|
2368840-66-6
|
C28H29F4N5O2
|
|
1,3-Benzenedicarboxylic acid, 4-methyl-5-(trifluoromethyl)-, 3-methyl ester
|
2368845-02-5
|
C11H9F3O4
|
|
Benzoic acid, 2-(bromomethyl)-5-formyl-3-(trifluoromethyl)-, methyl ester
|
2368845-05-8
|
C11H8BrF3O3
|
|
3,3'',5,5''-tetrakis(trifluoromethyl)-[1,1':4',1''-terphenyl]-2',5'-dicarbaldehyde
|
2368851-11-8
|
C24H10F12O2
|
|
1,?3,?5-?Benzenetriol, 2,?4,?6-?triamino-?, hydrochloride (1:3)
|
2368852-01-9
|
C6H10ClN3O3
|
|
Benzaldehyde, 4,4′-(1,10-phenanthroline-3,8-diyl)bis-
|
2368860-32-4
|
C26H16N2O2
|
|
2,2-difluoro-2-(pyridin-2-yl)ethan-1-amine hydrochloride
|
2368870-29-3
|
C7H9ClF2N2
|
|
3-(Azepan-1-ylmethyl)benzoic acid hydrochloride
|
2368870-42-0
|
C14H20ClNO2
|
|
1H-Indazole-6-carboxylic acid, 1-acetyl-3-methyl-, methyl ester
|
2368870-45-3
|
C12H12N2O3
|
|
3-(2-Chloroethyl)quinoline hydrochloride
|
2368871-60-5
|
C11H11Cl2N
|
|
Methyl 3-(bromomethyl)isonicotinate hydrobromide
|
2368871-68-3
|
C8H9Br2NO2
|
|
Methyl 3,5-dichloro-6-hydroxypicolinate
|
2368871-72-9
|
C7H5Cl2NO3
|
|
2-amino-4,5-dimethoxyphenol hydrochloride
|
2368871-78-5
|
C8H12ClNO3
|
|
4-(3-Iodopropyl)morpholine hydrochloride
|
2368872-24-4
|
C7H15ClINO
|
|
3-((1S)-1-AMINOPROPYL)PHENOL HCl
|
2368884-25-5
|
C9H14ClNO
|
|
4-((1S)-1-AMINOPROPYL)PHENOL HCl
|
2368884-26-6
|
C9H14ClNO
|
|
CMLD012072
|
2368900-33-6
|
C32H32N2O7
|
|
4-(8-Chloro-pyrido[3,4-d]pyrimidin-4-yl)-piperazine-1-carboxylic acid tert-butyl ester
|
2368909-17-3
|
|
|
3-Amino-2-chloro-6-trifluoromethyl-isonicotinic acid
|
2368909-21-9
|
C7H4ClF3N2O2
|
|
1-Piperazinecarboxylic acid, 4-(6,8-dichloropyrido[3,4-d]pyrimidin-4-yl)-, 1,1-dimethylethyl ester
|
2368909-23-1
|
C16H19Cl2N5O2
|